Praxis Precision Medicines, Inc. cotiza a 243.34 USD y tiene una capitalización bursátil de $6.8B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company's platforms include Cerebrum, a small molecule platform for CNS sma…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-2.87 | $-3.20 | $-3.50 |
| Estimado | $-3.50 | $-3.69 | $-3.68 | $-3.13 |
| Sorpresa | — | +22.2% | +13.0% | -11.8% |
| Métrica | PRAX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -34.5% | -40.4% | +5.9% |
| ROA | -32.3% | -32.0% | -0.3% |
| Current Ratio | 10.22 | 2.84 | +7.38 |
| Debt / Equity | — | 0.28 | — |